Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Infect Dis. 2014 Apr 1;209 Suppl 1:S28-31. doi: 10.1093/infdis/jit532.

Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.

Author information

  • 1US Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland.

Abstract

The resurgence of pertussis in the United States has stimulated considerable public health interest in developing new vaccination strategies to improve control of pertussis. The purpose of this article is to review the US Food and Drug Administration's regulatory framework for the prelicensure clinical evaluation of preventive vaccines and the clinical approaches that have been used to demonstrate effectiveness of US-licensed vaccines containing an acellular pertussis component.

KEYWORDS:

pertussis vaccines; regulatory pathways; vaccine effectiveness

PMID:
24626869
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk